.jpg "Richard L. Lalonde, PharmD photo")
Adjunct Professor
University of Florida
Richard Lalonde is Adjunct Professor, Center for Pharmacometrics and Systems Pharmacology, College of Pharmacy, University of Florida, and a consultant to the pharmaceutical industry. He was previously at Pfizer for 19 years and served as Vice President and Global Head of Clinical Pharmacology for the last 11 years of his tenure, until he retired in 2017. Prior to joining Pfizer, he was Scientific Director and Head of Clinical Pharmacology at Phoenix International in Montreal, Canada from 1991 to 1998. From 1984 to 1991 he was Assistant Professor and then a tenured Associate Professor and Vice Chair for Research in the Department of Clinical Pharmacy, College of Pharmacy, University of Tennessee, Memphis. Richard is a Fellow of the American College of Clinical Pharmacology, the American Association of Pharmaceutical Scientists and the American College of Clinical Pharmacy. He was President of ASCPT (2011 – 2012), a member of its Board of Directors (2010-2013) and in 2017 received the Gary Neil Prize for Innovation in Drug Development from the Society. Richard also received the International Society of Pharmacometrics Leadership Award in 2014. He has been a member of the editorial board of Clinical Pharmacology and Therapeutics since 2005 (Associate Editor 2007-2010). He served on the National Advisory General Medical Sciences Council at the National Institutes of Health from 2013 – 2016. Richard has been an invited speaker at various national and international meetings of professional societies, universities, and governmental/regulatory agencies in the US (FDA & NIH), Europe (EMA), Japan (PMDA) and China (CFDA). Over the past 40 years, his work has been focused on the quantitative application of pharmacokinetic and pharmacodynamic principles to the optimal development and utilization of drugs in patients. Richard is a graduate of the University of Minnesota (Pharm.D.) and the University of Toronto (B.Sc. Pharmacy).
Disclosure information not submitted.
Monday, January 10, 2022
8:00 PM – 9:00 PM ET
Friday, January 14, 2022
12:30 PM – 1:30 PM ET
.png)